The future of parkinson’s treatment – Personalised and precision medicine

Nataliya Titova, Peter Jenner, Kallol Ray Chaudhuri*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

7 Citations (Scopus)
328 Downloads (Pure)


The modern concept of Parkinson’s disease (PD) has changed and evolved and we consider Parkinson’s to be a multi-neurotransmitter dysfunction-related disorder with central and peripheral nervous system involvement. The clinical expression is thus a mixture of the outwardly evident motor symptoms and a range of ‘hidden’ non-motor symptoms. The complex underlying neuropathology of PD calls for a reassessment of the treatment strategies currently used. Treatment of PD is guideline-driven and in most cases based on a dopamine replacement strategy or surgical manipulation of brain dopaminergic pathways. Treatment of many non-dopaminergic non-motor and some motor symptoms, which have major effects on quality of life, continue to remain a key unmet need. Like in other chronic conditions such as rheumatology, the role of personalised medicine in PD needs to be increasingly considered. Personalised medicine for PD is not just a genetic approach to treatment but encompasses various strands of treatment. These include pharmacogenetic, pharmacological, as well as socio-demographic and lifestyle-related issues. Once these ‘enablers’ of personalised medicine are considered then satisfactory treatment for our patients with Parkinson’s can be achieved in an individualised manner. Future therapy for PD should move in that direction.

Original languageEnglish
Pages (from-to)15-16
Number of pages2
JournalEuropean Neurological Review
Issue number1
Early online date8 May 2017
Publication statusPublished - 1 Jun 2017


  • Non-motor symptoms
  • Parkinson’s disease
  • Personalised medicine
  • Precision medicine
  • Quality of life


Dive into the research topics of 'The future of parkinson’s treatment – Personalised and precision medicine'. Together they form a unique fingerprint.

Cite this